These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 15629358)

  • 61. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].
    Pan JP; Weng YS; Wu QQ
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A synthetic E7 gene of human papillomavirus type 16 that yields enhanced expression of the protein in mammalian cells and is useful for DNA immunization studies.
    Cid-Arregui A; Juárez V; zur Hausen H
    J Virol; 2003 Apr; 77(8):4928-37. PubMed ID: 12663798
    [TBL] [Abstract][Full Text] [Related]  

  • 63. tRNASer(CGA) differentially regulates expression of wild-type and codon-modified papillomavirus L1 genes.
    Gu W; Li M; Zhao WM; Fang NX; Bu S; Frazer IH; Zhao KN
    Nucleic Acids Res; 2004; 32(15):4448-61. PubMed ID: 15319446
    [TBL] [Abstract][Full Text] [Related]  

  • 64. RNA interference silences the human papillomavirus 6b/11 early gene E7 in vitro and in vivo.
    Chen XZ; Zhu KJ; Xu Y; Tang XY; Cai XZ; Zhang X; Cheng H
    Clin Exp Dermatol; 2010 Jul; 35(5):509-15. PubMed ID: 19874368
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Genomic and evolutionary comparison between SARS-CoV-2 and other human coronaviruses.
    Chen Z; Boon SS; Wang MH; Chan RWY; Chan PKS
    J Virol Methods; 2021 Mar; 289():114032. PubMed ID: 33290786
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases.
    Cheng MA; Farmer E; Huang C; Lin J; Hung CF; Wu TC
    Hum Gene Ther; 2018 Sep; 29(9):971-996. PubMed ID: 29316817
    [TBL] [Abstract][Full Text] [Related]  

  • 67. An artificial PAP gene breaks self-tolerance and promotes tumor regression in the TRAMP model for prostate carcinoma.
    Spies E; Reichardt W; Alvarez G; Groettrup M; Ohlschläger P
    Mol Ther; 2012 Mar; 20(3):555-64. PubMed ID: 22086231
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Papillomavirus-specific CD4+ T cells exhibit reduced STAT-5 signaling and altered cytokine profiles in patients with recurrent respiratory papillomatosis.
    James EA; DeVoti JA; Rosenthal DW; Hatam LJ; Steinberg BM; Abramson AL; Kwok WW; Bonagura VR
    J Immunol; 2011 Jun; 186(11):6633-40. PubMed ID: 21531896
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Induction of antigen-specific CTL and antibody responses in mice by a novel recombinant tandem repeat DNA vaccine targeting at mucin 1 of pancreatic cancer.
    Wu WC; Jin DY; Lou WH; Wang DS; Qin XY
    J Cancer Res Clin Oncol; 2010 Dec; 136(12):1861-8. PubMed ID: 20229033
    [TBL] [Abstract][Full Text] [Related]  

  • 70. DNA/amphiphilic block copolymer nanospheres promote low-dose DNA vaccination.
    McIlroy D; Barteau B; Cany J; Richard P; Gourden C; Conchon S; Pitard B
    Mol Ther; 2009 Aug; 17(8):1473-81. PubMed ID: 19417740
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The efficacy of a DNA vaccine containing inserted and replicated regions of the E7 gene for treatment of HPV-16 induced tumors.
    Brinkman JA; Xu X; Kast WM
    Vaccine; 2007 Apr; 25(17):3437-44. PubMed ID: 17241713
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Optimized FaeG expression and a thermolabile enterotoxin DNA adjuvant enhance priming of an intestinal immune response by an FaeG DNA vaccine in pigs.
    Melkebeek V; Sonck E; Verdonck F; Goddeeris BM; Cox E
    Clin Vaccine Immunol; 2007 Jan; 14(1):28-35. PubMed ID: 17108289
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A DNA vaccine encoding a codon-optimized human papillomavirus type 16 E6 gene enhances CTL response and anti-tumor activity.
    Lin CT; Tsai YC; He L; Calizo R; Chou HH; Chang TC; Soong YK; Hung CF; Lai CH
    J Biomed Sci; 2006 Jul; 13(4):481-8. PubMed ID: 16649071
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparison of DNA- and mRNA-transfected mouse dendritic cells as potential vaccines against the human papillomavirus type 16 associated oncoprotein E7.
    Dell K; Klein C; Gissmann L
    Antivir Ther; 2008; 13(4):495-509. PubMed ID: 18672528
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Modification of HPV 16 E7 genes: correlation between the level of protein expression and CTL response after immunization of C57BL/6 mice.
    Steinberg T; Ohlschläger P; Sehr P; Osen W; Gissmann L
    Vaccine; 2005 Jan; 23(9):1149-57. PubMed ID: 15629358
    [TBL] [Abstract][Full Text] [Related]  

  • 76. An improved rearranged Human Papillomavirus Type 16 E7 DNA vaccine candidate (HPV-16 E7SH) induces an E7 wildtype-specific T cell response.
    Ohlschläger P; Pes M; Osen W; Dürst M; Schneider A; Gissmann L; Kaufmann AM
    Vaccine; 2006 Apr; 24(15):2880-93. PubMed ID: 16472545
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Codon optimized expression of HPV 16 E6 renders target cells susceptible to E6-specific CTL recognition.
    Samorski R; Gissmann L; Osen W
    Immunol Lett; 2006 Sep; 107(1):41-9. PubMed ID: 16949679
    [TBL] [Abstract][Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.